MOISTURESTAY (REVLON)

K022626 · Raymond Industrial, Ltd. · IMC · Oct 29, 2002 · Physical Medicine

Device Facts

Record IDK022626
Device NameMOISTURESTAY (REVLON)
ApplicantRaymond Industrial, Ltd.
Product CodeIMC · Physical Medicine
Decision DateOct 29, 2002
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 890.5110
Device ClassClass 2
AttributesTherapeutic

Intended Use

Useful in symptomatic relief of pain caused by arthritis, bursitis, and chronic joint inflammation. Relaxes muscles, relieves stiffness and muscle spasm. Stimulates circulation and for other conditions where heat is indicated.

Device Story

Revlon RVS1212 (MoistureStav) Luxury Paraffin Spa; paraffin bath device for heat therapy. Operates by melting paraffin wax to provide therapeutic heat to extremities. Used in home or clinical settings for symptomatic relief of pain from arthritis, bursitis, and chronic joint inflammation; relaxes muscles; relieves stiffness/spasms; stimulates circulation. Patient immerses affected area in heated wax. Simple thermal device; no complex electronics or software.

Clinical Evidence

Bench testing only; no clinical data provided.

Technological Characteristics

Paraffin bath heating unit; thermal energy source; standard electrical heating element for wax melting; form factor designed for extremity immersion. No software or complex algorithms.

Indications for Use

Indicated for patients requiring symptomatic relief of pain associated with arthritis, bursitis, and chronic joint inflammation; also indicated for muscle relaxation, relief of stiffness/spasms, and stimulation of circulation where heat therapy is appropriate.

Regulatory Classification

Identification

A paraffin bath is a device intended for medical purposes that consists of a tub to be filled with liquid paraffin (wax) and maintained at an elevated temperature in which the patient's appendages (e.g., hands or fingers) are placed to relieve pain and stiffness.

Special Controls

*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, with three parallel lines forming the staff and a snake winding around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the caduceus. ## Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## OCT 2 9 2002 Raymond Industrial, Ltd. c/o Mr. Robert T. Wagner President AEGIS, Inc. 972 Weedon Drive, NE St. Petersburg, Florida 33702 Re: K022626 Trade/Device Name: Revlon RVS1212 (MoistureStav) Luxury Paraffin Spa Regulation Number: 21 CFR 890.5110 Regulation Name: Paraffin Bath Regulatory Class: Class II Product Code: IMC Dated: September 1, 2002 Received: October 4, 2002 Dear Mr. Wagner: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may. therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ Page 2 - Mr. Robert Wagner This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, D. Mark N. Millikan Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## STATEMENT OF INDICATIONS FOR USE Applicant: Helen of Troy 510(K) Number (if known): Device Name: Luxury Paraffin Bath Indications For Use: Useful in symptomatic relief of pain caused by arthritis, bursitis, and chronic joint inflammation. Relaxes muscles, relieves stiffness and muscle spasm. Stimulates circulation and for other conditions where heat is indicated. Concurrence of CDRH, Office of Device Evaluation (ODE) (Per 21 CFR 801.109) L. Mark N. Millman (Division Sign-Off) Division of General, Restorative and Neurological Dev Page G1 510(k) Number
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...